Literature DB >> 9780230

Phorbol ester causes ligand-independent activation of the androgen receptor.

C Darne1, G Veyssiere, C Jean.   

Abstract

We have examined the human androgen receptor (hAR) for its ability to activate AR-dependent transcription of a transgene in a ligand-independent manner. The transcriptional activity was determined by analysis of chloramphenicol acetyltransferase (CAT) activity in T47D cells cotransfected with a plasmid expressing the hAR and a natural AR-regulated promoter (the MVDP androgen-dependent enhancer) ligated to the reporter CAT gene. In this study, the effects of the protein kinase C (PKC) activator 12-O-tetradecanoyphorbol-13 acetate (TPA) on AR activity were tested. We demonstrated that in the absence of androgen, TPA enhanced AR-mediated transactivation by 10-12-fold. This effect was specific of the PKC pathway since stimulation to the PKA pathway did not activate the unliganded AR. This ligand-independent pathway can function through another androgen-regulated promoter as shown by the use of the mouse mammary tumor virus MMTV-CAT reporter. The human glucocorticoid receptor (hGR) and the rabbit progesterone receptor (rPR) could not be activated by TPA, indicating that the effects are not universal for steroid receptors. A reporter plasmid containing the MVDP androgen response element (ARE) in front of the thymidine kinase promoter ligated to the CAT gene was activated by DHT but not by TPA, indicating that the context of the natural promoter is critical for ligand-independent activation of the AR. Exogenous c-jun enhanced transcriptional activation by the AR in a ligand-dependent manner, but had no effect in the absence of DHT. Base pair substitutions in both AR-binding (5'-TGTTCT-3' to 5'-TTTTTT-3') and NF1-binding (5'-GTGGCTG-3' to 5'-GTTTTTG-3') sites resulted in a loss of TPA responsiveness. Our results suggest that ligand-independent activation of the AR by TPA results from interaction of unliganded AR with other proteins in the transcription machinery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780230     DOI: 10.1046/j.1432-1327.1998.2560541.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

Review 1.  Minireview: Tipping the balance: ligand-independent activation of steroid receptors.

Authors:  Marcela A Bennesch; Didier Picard
Journal:  Mol Endocrinol       Date:  2015-01-27

2.  Using weighted entropy to rank chemicals in quantitative high-throughput screening experiments.

Authors:  Keith R Shockley
Journal:  J Biomol Screen       Date:  2013-09-20

3.  Cross-talk between steroid-receptor-mediated and cell-membrane-receptor-mediated signalling pathways results in the in vivo modulation of c-Met and ornithine decarboxylase gene expression in mouse kidney.

Authors:  M Dudkowska; A Stachurska; W Chmurzyska; B Grzelakowska-Sztabert; M Manteuffel-Cymborowska
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

4.  Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.

Authors:  Mujib M Rahman; Hiroshi Miyamoto; Henry Lardy; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

5.  Species, interindividual, and tissue specificity in endocrine signaling.

Authors:  C Walker; S A Ahmed; T Brown; S M Ho; L Hodges; G Lucier; J Russo; N Weigel; T Weise; J Vandenbergh
Journal:  Environ Health Perspect       Date:  1999-08       Impact factor: 9.031

Review 6.  Degradation and beyond: control of androgen receptor activity by the proteasome system.

Authors:  Tomasz Jaworski
Journal:  Cell Mol Biol Lett       Date:  2006       Impact factor: 5.787

7.  Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.

Authors:  Manqi Zhang; Egla Suarez; Judy L Vasquez; Lubov Nathanson; Leif E Peterson; Kimal Rajapakshe; Paul Basil; Nancy L Weigel; Cristian Coarfa; Irina U Agoulnik
Journal:  Oncogene       Date:  2018-09-18       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.